search results for 

Important markets and competitive position

Fresenius operates in about 80 countries through its subsidiaries. The main markets are North America and Europe with 42% and 40% of sales, respectively.

Fresenius Medical Care holds the leading position in dialysis care as it serves about 11% of all dialysis patients, as well as in dialysis products, with a market share of about 34%. Fresenius Kabi holds leading market positions in Europe and has strong positions in the growth markets of Asia-Pacific and Latin America. In the United States, Fresenius Kabi is one of the leading suppliers of generic IV drugs. Fresenius Helios is the largest hospital operator in Germany. Fresenius Vamed is also one of the world’s leading companies in its field.

Continue reading:
Legal and economic factors